CDT Equity Inc. (CDT) Fair Value 2026

CDT · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.3 /10

32 fundamental signals · 0 models active

Value Trap Risk

WARN (47/100)

Quick Summary — As of 2026-08-31, CDT Equity Inc. (CDT) trades at $1.68. QOC: 4.3/10. Value Trap Risk: 47/100 (WARN). 0/13 models active.

Key Facts

Ticker
CDT
Price
$1.68
Quality Score
4.3/10
Value Trap Risk
47/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 47 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give CDT?

0 Intrinsic Value Models vs. Current Price ($1.68)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is CDT Equity Inc. (CDT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, CDT Equity Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About CDT?

0 of 13 models are currently active for CDT. See which stocks rank higher →

How Does CDT Rank in Biotechnology?

Among 625 Biotechnology stocks, CDT ranks #491 by Quality of Company score. CirclFi's QOC score of 4.3/10 evaluates 32 fundamental signals. A score of 4.3 reflects mixed fundamentals.

See all Most Undervalued Biotechnology Stocks →

Within the Biotechnology space, CDT Equity Inc. competes in an environment where partnership revenue often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is CDT a Value Trap?

CirclFi's Value Trap algorithm assigns CDT a score of 47/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for CDT Equity Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, CDT Equity Inc.'s fundamental quality profile registers 4.3/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CDT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy CDT Equity Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

REVBRevelation Biosciences, Inc.QOC 4.3SMNRSemnur Pharmaceuticals, Inc.QOC 4.3INKTMiNK Therapeutics, Inc.QOC 4.3FBRXForte Biosciences, Inc.QOC 4.3ANVSAnnovis Bio, Inc.QOC 4.3CLDICalidi Biotherapeutics, Inc.QOC 4.3TECHBio-Techne CorporationQOC 8.3INBXInhibrx Biosciences, Inc.QOC 5.8ARTVArtiva Biotherapeutics, Inc.QOC 4.9EXELExelixis, Inc.QOC 9.6INCYIncyte CorporationQOC 9.5

Read investment analysis: REVB · SMNR · INKT · FBRX · ANVS · CLDI · TECH · INBX · ARTV · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to CDT?

5 companies across all industries closest to CDT’s Quality of Company score of 4.3/10.

LIVGLivento Group, Inc.QOC 4.3PALProficient Auto Logistics, Inc.QOC 4.3AIEVThunder Power Holdings, Inc.QOC 4.3HYMCHycroft Mining Holding CorporationQOC 4.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LIVG · PAL · AIEV · HYMC · NVDA

Where Does CDT Sit in CirclFi's Biotechnology Rankings?

CDT is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About CDT Equity Inc.’s Valuation?

What is CDT Equity Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for CDT Equity Inc. (CDT). The Quality of Company score is 4.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CDT overvalued or undervalued right now?

At $1.68, 0 of 0 active models suggest CDT may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits CDT Equity Inc.'s business model in Biotechnology.

What does a Quality of Company score of 4.3 mean for CDT?

CDT Equity Inc.'s QOC of 4.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on CDT?

CirclFi analyzes CDT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is CDT a value trap in 2026?

CDT Equity Inc.'s Value Trap score is 47/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns CDT Equity Inc. (CDT) a Quality of Company score of 4.3/10 across 32 fundamental signals as of 2026-08-31.” Source: circlfi.com/stock/CDT/ · Methodology
Primary sources for this CDT valuation
  • Financial statements: CDT Equity Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001896212) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CDT as of ; valuations recomputed .